Hospital Mater Dei SA
6.30
BRL
+0.06
(+0.96%)
ISIN
BRMATDACNOR4
Return %
Stock
S&P 500
1Y
50.36
14.20
3Y
-14.75
81.12
5Y
-59.09
68.34
Capital Structure
BRL
•
in mil. unless spec.Working Capital
BRL
•
in mil. unless spec.Growth Rates
BRL
•
in mil. unless spec.Quarterly Revenue
BRL
•
in mil. unless spec.Quarterly Earnings Per Share
BRL
•
in mil. unless spec.Quarterly Dividends Per Share
BRL
•
in mil. unless spec.Company Description
- CEO
- Jose Henrique Dias Salvador
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Belo Horizonte Brazil
- IPO Date
- Apr 16, 2021
- Website
- materdei.com.br
- Similar Companies
- Business
- Hospital Mater Dei S.A. operates as an integrated private healthcare network providing comprehensive inpatient, outpatient, surgical, and diagnostic medical care in Brazil. Founded in 1980 and headquartered in Belo Horizonte, Minas Gerais, the company serves individual private patients, corporate clients, and health insurance beneficiaries through a multi-regional hub-and-spoke hospital infrastructure. The company provides a wide array of specialized healthcare services organized across primary clinical divisions, comprising: inpatient and emergency care services, including adult, pediatric, and neonatal intensive care units (ICU), 24/7 urgent care, observation units, and day-hospital facilities; specialized centers of excellence and high-complexity surgery, encompassing robotic-assisted surgery, cardiovascular interventions, hemodynamics, neurosurgery, orthopedics, traumatology, bone marrow transplantation, bariatric procedures, and comprehensive maternity, obstetric, and neonatal care; integrated cancer care through Mater Dei Oncologia, offering clinical oncology, radiation oncology, chemotherapy infusion, surgical oncology, and specialized patient navigation; comprehensive diagnostic and clinical laboratory testing, featuring magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET-CT), digital mammography, ultrasound, endoscopy, clinical pathology, molecular diagnostics, and genetic testing; outpatient medical consultations across numerous specialties, including cardiology, neurology, gastroenterology, endocrinology, dermatology, and pediatrics; and preventive, post-acute, and digital health services, encompassing executive check-up programs, telemedicine consultations, occupational health management, physical therapy, and multidisciplinary rehabilitation. Geographically, Mater Dei manages healthcare facilities across several major Brazilian regions, with key operations situated in the State of Minas Gerais (including Mater Dei Santo Agostinho, Mater Dei Contorno, Mater Dei Betim-Contagem, and Hospital Santa Clara), Bahia (Mater Dei Salvador and Hospital EMEC), Pará (Hospital Porto Dias), and Goiás. In recent developments, Hospital Mater Dei S.A. has focused on expanding and consolidating its regional footprint following its expansion into strategic metropolitan markets outside Minas Gerais. Key initiatives include the operational ramp-up and service line maturation of Mater Dei Salvador, alongside the operational integration and modernization of acquired regional hospital assets such as Hospital Porto Dias in Belém and Hospital EMEC in Feira de Santana. The company has also expanded its high-margin robotic surgery platforms and specialized oncology network across its regional hubs, entered into enhanced commercial and value-based healthcare partnerships with private health maintenance organizations (HMOs) and insurers, and deployed advanced hospital management systems, centralized electronic medical records, and digital telehealth platforms to optimize operational capacity and clinical outcomes.